Clinical Trials Browser

Phase 2 × Radiation Dose Hypofractionation × Tumor-Agnostic × Clear all

NCT05530200 2022-09-07

PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors.

Phase 2 Unknown

Neoplasm Metastasis